Balanced news tone
News Sentiment
4506 sentiment intelligence
Sumitomo Pharma Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
76/100 classification confidence.
directly relevant articles
high-authority source matches
-10.1% over one week, +1.9% over four weeks, trend inactive, and materially above fair value.
Sumitomo Pharma Shares Drop After Stem-Therapy Backing
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Sumitomo Pharma Shares Drop After Stem-Therapy Backing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Feb 2026 08:00
- Source
- Bloomberg.com
Sumitomo Pharma Q3 FY2025 slides: North American sales drive 408% profit surge
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 06 Feb 2026 08:00
- Source
- Investing.com
Is Sumitomo Pharma (TSE:4506) Using Too Much Debt?
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 02 Jan 2026 08:00
- Source
- simplywall.st
Sumitomo Pharma Forms New Entity for Asian Business Spinoff
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2025 07:00
- Source
- marketscreener.com
Establishment of a Pharmaceutical Strategic Platform: Succession of Sumitomo Pharma’s Business in Asia
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Apr 2025 07:00
- Source
- marubeni.com
Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Oct 2022 07:00
- Source
- PR Newswire
Sumitomo Offers to Buy All of Myovant in Deal Worth $2.5 Billion
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 03 Oct 2022 07:00
- Source
- Bloomberg.com
Sumitovant Biopharma and Sumitomo Pharma Announce Offer to Acquire Outstanding Shares of Myovant Sciences
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Oct 2022 07:00
- Source
- PR Newswire